Fresenius | FRE - Gross Profit On Sales

Stock Price
39.21
Daily Change
-0.01 -0.01%
Monthly
-10.45%
Yearly
-10.96%
Q2 Forecast
37.79

Fresenius reported EUR1.51B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Akzo Nobel EUR 936M 102M Dec/2025
Alcon AG USD 1.69B 175M Mar/2026
AstraZeneca USD 12.61B 225M Mar/2026
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 6.94B 1.58B Dec/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
DaVita Healthcare Partners USD 895.46M 128.1M Mar/2026
Demant DKK 8.82B 277M Dec/2025
E.ON EUR 5.41B 672M Mar/2026
Essilor EUR 8.3B 547M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Getinge SEK 5.05B 1.5B Dec/2024
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GN Store Nord DKK 2.5B 344M Dec/2025
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
RWE EUR 2.74B 2.02B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025